NPI: 1851343909 · VICTORIA, TX 77901 · Ambulatory Surgical Clinic/Center · NPI assigned 05/17/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 05/17/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 2,043 | $145K |
| 2021 | 37,489 | $2.36M |
| 2022 | 37,572 | $2.28M |
| 2023 | 27,277 | $2.09M |
| 2024 | 11,598 | $858K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 8,711 | 8,319 | $3.71M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 21,424 | 20,640 | $1.45M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1,518 | 1,482 | $677K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6,975 | 6,772 | $482K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,761 | 4,634 | $324K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,711 | 2,508 | $113K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 716 | 550 | $86K |
| 87430 | 3,698 | 3,588 | $81K | |
| 87400 | 3,220 | 1,765 | $67K | |
| 80053 | Comprehensive metabolic panel | 7,592 | 6,763 | $60K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 335 | 318 | $59K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,350 | 3,171 | $59K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1,519 | 1,483 | $57K |
| 87486 | 1,519 | 1,483 | $57K | |
| 87581 | 1,519 | 1,483 | $57K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 940 | 917 | $55K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8,613 | 7,692 | $47K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,038 | 1,013 | $39K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 153 | 143 | $38K |
| 71045 | Radiologic examination, chest; single view | 2,048 | 1,932 | $31K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 987 | 964 | $31K |
| G0378 | Hospital observation service, per hour | 27 | 26 | $27K |
| 81001 | 9,084 | 8,580 | $26K | |
| 81025 | 2,326 | 2,218 | $19K | |
| 87081 | 1,959 | 1,895 | $17K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 690 | 675 | $11K |
| CP007 | 150 | 94 | $11K | |
| 70450 | Computed tomography, head or brain; without contrast material | 192 | 183 | $7K |
| 76801 | 60 | 53 | $5K | |
| 83690 | 1,024 | 954 | $5K | |
| 87088 | 956 | 895 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 676 | 637 | $3K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,085 | 1,024 | $3K |
| 84484 | 972 | 722 | $3K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 55 | 55 | $3K |
| 71046 | Radiologic examination, chest; 2 views | 166 | 162 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 435 | 385 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 48 | 24 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 182 | 169 | $2K |
| 87420 | 92 | 90 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 660 | 609 | $2K |
| 82553 | 540 | 396 | $2K | |
| 93976 | 14 | 12 | $1K | |
| 80305 | 79 | 76 | $825.10 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 172 | 109 | $551.74 |
| 82550 | 407 | 307 | $542.44 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 375 | 293 | $369.96 |
| 84702 | 30 | 25 | $343.69 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1,628 | 1,584 | $323.92 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 77 | 70 | $298.44 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 243 | 53 | $296.11 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 25 | 25 | $271.61 |
| 85027 | 193 | 183 | $239.19 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 226 | 206 | $234.80 |
| 86901 | 178 | 153 | $203.31 | |
| 86900 | 179 | 153 | $203.31 | |
| 96361 | Intravenous infusion, hydration; each additional hour | 80 | 77 | $198.73 |
| 86850 | 30 | 27 | $177.95 | |
| 85730 | 476 | 423 | $159.48 | |
| 84443 | Thyroid stimulating hormone (TSH) | 67 | 65 | $155.92 |
| 85610 | 561 | 497 | $130.91 | |
| 87186 | 123 | 82 | $101.78 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 180 | 161 | $100.25 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 49 | 48 | $83.19 |
| 36415 | Collection of venous blood by venipuncture | 2,947 | 2,172 | $65.75 |
| 87077 | 44 | 43 | $61.11 | |
| 82962 | 1,059 | 569 | $57.35 | |
| 0240U | 218 | 208 | $53.92 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 275 | 253 | $49.82 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 13 | 13 | $35.76 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 331 | 309 | $26.00 |
| 85007 | 24 | 24 | $19.14 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 127 | 117 | $6.00 |
| 83735 | 15 | 13 | $5.63 | |
| 36416 | 704 | 520 | $3.85 | |
| J2704 | Injection, propofol, 10 mg | 53 | 51 | $0.00 |
| 83880 | 15 | 12 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 36 | 36 | $0.00 |